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Abstract
Background: Type 1 fimbriae are the most commonly found fimbrial appendages on the outer membrane of
Salmonella enterica serotype Typhimurium. Previous investigations indicate that static broth culture favours S.
Typhimurium to produce type 1 fimbriae, while non-fimbriate bacteria are obtained by growth on solid agar
media. The phenotypic expression of type 1 fimbriae in S. Typhimurium is the result of the interaction and
cooperation of several genes in the fim gene cluster. Other gene products that may also participate in the
regulation of type 1 fimbrial expression remain uncharacterized.
Results: In the present study, transposon insertion mutagenesis was performed on S. Typhimurium to generate
a library to screen for those mutants that would exhibit different type 1 fimbrial phenotypes than the parental
strain. Eight-two mutants were obtained from 7,239 clones screened using the yeast agglutination test. Forty-four
mutants produced type 1 fimbriae on both solid agar and static broth media, while none of the other 38 mutants
formed type 1 fimbriae in either culture condition. The flanking sequences of the transposons from 54 mutants
were cloned and sequenced. These mutants can be classified according to the functions or putative functions of
the open reading frames disrupted by the transposon. Our current results indicate that the genetic determinants
such as those involved in the fimbrial biogenesis and regulation, global regulators, transporter proteins, prophage-
derived proteins, and enzymes of different functions, to name a few, may play a role in the regulation of type 1
fimbrial expression in response to solid agar and static broth culture conditions. A complementation test revealed
that transforming a recombinant plasmid possessing the coding sequence of a NAD(P)H-flavin reductase gene ubiB
restored an ubiB mutant to exhibit the type 1 fimbrial phenotype as its parental strain.
Conclusion: Genetic determinants other than the fim genes may involve in the regulation of type 1 fimbrial
expression in S. Typhimurium. How each gene product may influence type 1 fimbrial expression is an interesting
research topic which warrants further investigation.
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Background
Salmonellosis is one of the important causes of food-
borne diseases throughout the world [1]. Salmonella enter-
ica  contains more than 2,300 serotypes among which
Typhimurium is an important causative agent of gastroen-
teritis. Adhesion of bacteria to the host epithelial cells is a
prerequisite step in establishing infection. Specific adhe-
sion requires the interaction of specialized complemen-
tary molecules in a ligand-receptor interaction between
bacterial surfaces and host tissues [2]. Proteinaceous hair-
like structures called fimbriae on the surface of bacteria
have been implicated in such an event [3]. Many members
of the family Enterobacteriaceae including Salmonella pro-
duce type 1 fimbriae, the most commonly found type of
fimbrial appendages [4]. Type 1 fimbriae comprise a fam-
ily of rod-shaped organelles which are 7 nm in diameter
and 0.2–2.0 μm long [5]. Type 1 fimbriae adhere to differ-
ent cell types including erythrocytes, leukocytes, intestinal
cells, respiratory cells, protozoa, yeast, fungal hyphae, and
plant root hairs [6]. Several studies indicated that type 1
fimbriae also contribute to virulence [7-9]. For example,
type 1 fimbriae expressing S. Typhimurium caused persist-
ent infection in swine [7]. Type 1 fimbriae may also mod-
ulate the bacterial tropism to the gut of the host [8], and
type 1-fimbriated Salmonella were more virulent than the
fim-minus ones [9]. The fact that more than 80% of Salmo-
nella isolates produce this fimbrial type suggests that type
1 fimbriae play an important role at some stage in the life
cycle of bacteria [10].
Phenotypic variation of the expression of type 1 fimbriae
in S. Typhimurium was first characterized by Old et al.
[11,12]. They described a biphasic growth pattern associ-
ated with the outgrowth of fimbriate bacteria incubated in
static, liquid broth culture. Briefly, strongly type 1 fimbri-
ate phase S. Typhimurium cells were isolated following
serial passage every 48 h in static broth culture. Non-fim-
briate phase bacteria were obtained by growth on solid
media.
Current data indicate that the phenotypic expression of
type 1 fimbriae in S. Typhimurium is the result of the
interaction and cooperation of several genes in the fim
gene cluster [13-18]. The FimZ transcriptional factor acti-
vates the fimA  expression by binding to the fimA  pro-
moter, and in addition, FimZ also positively regulates its
own transcription [13]. FimZ requires another co-activa-
tor FimY to activate fimA  expression, however, no evi-
dence has revealed any interaction of FimY and the fimA
promoter [19]. Interestingly, fimY  gene possesses five
rarely used arginine codon which is recognized by an
arginine tRNA gene fimU. A S. Typhimurium fimU mutant
did not produce type 1 fimbriae and the fimY translation
was inhibited [16,17]. fimU modulates the fimY expres-
sion in the translational level. A fimW deleted strain, on
the contrary, overproduced type 1 fimbriae as compared
to the parental strain. This negative regulation was pro-
posed to be mediated through an inhibitory effect on the
FimZ protein by a FimW-FimZ protein-protein interaction
[15]. Other than gene products within the fim gene clus-
ter, McFarland et al. recently reported that a knockout
mutation in lrp, encoding the leucine-responsive regula-
tory protein (LRP), was non-fimbriated [20]. They dem-
onstrated that LRP positively regulated type 1 fimbrial
expression by binding to the promoter region of fimZ
[20]. Other gene products that may play a role in type 1
fimbrial expression were seldom characterized. Our long-
term goal in the laboratory is focused on finding any
genetic determinants, other than those previously
described within the fim gene cluster, which may also play
a role in the phenotypic expression of type 1 fimbriae in
S. Typhimurium. Initially we were interested in character-
izing the genetic elements that may be associated with the
ability of S. Typhimurium to switch type 1 fimbrial
expressions in response to solid agar and static broth cul-
ture conditions. We used transposon mutagenesis to gen-
erate a library for S. Typhimurium and screened mutants
that exhibited different type 1 fimbrial phenotypes than
the parental strain between solid agar and static broth cul-
ture conditions. The flanking DNA fragments of the trans-
poson insertion sites in the mutants of interest were
cloned and sequenced. Herein, we report on the genetic
determinants in S. Typhimurium that may play a role in
the regulation of type 1 fimbrial expression between solid
agar and static broth culture conditions.
Results
Construction of a transposon mutant library of S. 
Typhimurium
In order to identify any genetic determinant that is
responsible for S. Typhimurium to regulate type 1 fim-
brial expression between solid agar and static broth cul-
tures, we used a transposon mutagenesis technique to
construct a transposon library. We obtained a library with
approximately 8,000 clones.
Screening of S. Typhimurium transposon mutants that 
exhibited different type 1 fimbrial phenotypes than the 
parental strain
In total, 7,239 transposon mutants were screened for
those which exhibited different type 1 fimbrial pheno-
types as compared to the parental strain S. Typhimurium
LB5010. The expression of type 1 fimbriae was deter-
mined by yeast agglutination test. S. Typhimurium
LB5010, when grown in static broth culture for 36–48 h,
agglutinated Candida albicans on a glass slide. These bacte-
rial cells produced type 1 fimbriae on the outer membrane
when negatively stained with phosphotungstic acid and
observed under electron microscopy (Figure 1, Panel A).
On the contrary, S. Typhimurium LB5010 did not aggluti-BMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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Observation of type 1 fimbriae in S. Typhimurium LB5010 by electron microscopy Figure 1
Observation of type 1 fimbriae in S. Typhimurium LB5010 by electron microscopy. Panel A. S. Typhimurium 
LB5010 cells produced type 1 fimbrial appendages on the outer membrane (arrow) when cultured in LB static broth at 37°C 
for 48 hr (20,000 ×). Panel B. S. Typhimurium LB5010 cells did not produce type 1 fimbrial appendages on the outer membrane 
when cultured on LB agar at 37°C for 18 hr (20,000 ×). Bacterial cells were negatively stained with 2% of phosphotungstic acid.BMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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Table 1: S. Typhimurium mutants that exhibited different type 1 fimbrial phenotypes than the parental strain
Category Mutant Phenotype Genea Function
(agar, broth)
Fimbrial biosynthesis and regulation K2 -, - fimZ Positive regulator of type 1 fimbriae major subunit gene fimA
K14 -, - fimY Positive regulator of type 1 fimbriae major subunit gene fimA
K40 -, - fimA Major subunit of type 1 fimbriae
K66 -, - fimD Fimbrial usher protein of FimA
K75 -, - fimC Fimbrial chaperone protein of FimA
K44 -, - fimH Adhesin of type 1 fimbriae
K70 +, + lpfB Fimbrial chaperone protein of long polar fimbriae
K61 +, + pefI Regulator of plasmid-encoded fimbriae
K23 +, + stbC Fimbrial usher protein of Stb fimbriae
Putative cytoplasmic protein K1 +, + STM1078 Putative cytoplasmic protein
K28 +, + STM4529 Putative cytoplasmic protein
Global regulator K46 -, - lrp Leucine-responsive regulatory protein
K15 -, - hupA Histone-like DNA binding protein
Membrane associated protein K17, +, + yhjV Putative transporter protein
K39 -, - STM1128 Putative sodium/glucose cotransporter
K45 -, - yihO Putative glycoside-pentoside-hexuronide (GPH) family transport protein
K50 +, + STM2532 Putative inner membrane lipoprotein
K52 +, + STM2486 Putative inner membrane protein
K54 -, - yjiH Putative inner membrane protein
K72 +, + mgtB Mg2+ transporter protein
K30 +, + narK Nitrate/nitrite transporter protein
Cell envelope associated protein K60 +, + ytfB Putative cell envelope opacity-associated protein A
Periplasmic protein K69 +, + ydbH Putative periplasmic protein
Ribosome modulation factor K56 -, - rmf Ribosome modulation factor
Type III secretion system K55 -, - ssaB Effector protein of type III secretion system
K59 +, + invB Chaperone protein for SopE/SopE2
K63 -, - ssaV Apparatus protein for intracellular trafficking and secretion
Prophage-derived protein K11 +, + STM4200 Putative phage tail protein H
K33 +, + sseI Gifsy-2 prophage putative type III secreted effector protein
K19 -, - STM1041 Gifsy-2 prophage probable minor tail protein
Sensor protein K51 +, + ssrA Sensor component of type III secretion system
K58 +, + yehU Sensor component
Transcription termination factor K73 -, - nusA Transcription termination factor
Enzymes K3 -, - cafA Endoribonuclease
K5 +, + res Subunit of type III restriction-modification enzyme
K8 +, + STM4467 Putative arginine deiminase
K16 +, + STM1627 Alcohol dehydrogenase class III
K31 +, + STM2446 Putative iron-dependent peroxidase
K41 -, - nuoE NADH dehydrogenase I chain E
K37 +, + yafA Putative hydrolase
K43 -, - miaA Isopentenylpyrophosphate transferase
K38 -, - prC C-terminal protease for penicillin binding protein
K47 -, - atpH Membrane-bound ATP synthase
K48 +, + ubiB NAD(P)H-flavin reductase
K49 -, - ydiF Putative acetyl-CoA: acetoacetyl-CoA transferase
K53 +, + tdK Thymidine kinase
K65 +, + pps Phosphoenolpyruvate synthase
K57 +, + ybjX Putative enzyme with unknown function
K67 +, + pncA Nicotinamidase/pyrazinamidase
K68 +, + rfaB Lipopolysaccharide 1,6-galactosyltransferase
K71 +, + xapB Xanthosine permease
K64 +, + STM1940 Putative cell wall-associated hydrolase
K74 +, + cbiA Cobyrinic acid a, c-diamide synthase
K42 -, - aroA 3-enolpyruvylshikimate-5-phosphate synthetase
a: The gene that was disrupted by the transposon insertion is listed. The annotation of S. Typhimurium LT2 genome is used if the transposon 
insertion was present in a gene which is uncharacterized and unnamed.BMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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nate C. albicans on a glass slide when bacterial cells were
prepared from solid agar medium grown for 16–18 h. The
absence of agglutination correlated with the fact that no
type 1 fimbriae were observed by electron microscopy
(Figure 1, Panel B). Fifty-four mutants verified by South-
ern blot to have a single unique transposon insertion were
selected for further investigation (Figure 2). For those
strains with multiple transposon insertions (Figure 2, lane
6 for example) were currently excluded from the present
study. This could be due to partial digestion of the
genomic DNA or multiple transposons inserted into one
bacterial strain. These 54 mutants no longer exhibited the
same type 1 fimbrial phenotype as the parental strain,
among which 31 mutants produced type 1 fimbriae in
both culture conditions, while another 23 mutants pro-
duced type 1 fimbriae in neither culture condition. The
genes inactivated in the mutants were identified by clon-
ing and sequencing the DNA fragments adjacent to the
transposon insertion sites. The DNA sequences were used
to search against the genomic sequence of S. Typhimu-
rium. The position of the transposon insertion site was
determined along with whether or not a transposon inser-
tion site was located in or near an open reading frame
(ORF), as predicted by the annotated genomic sequences.
In the present study, we only focused on those mutants
that demonstrated disruptions in ORFs; these types of
mutation are expected to disrupt the functions of the
ORFs involved. Table 1 lists those mutants. Transposons
which disrupted between ORFs were excluded in the
present study.
A representative Southern blot demonstrating hybridization of the genomic DNA cleaved with EcoRI with a DIG-labeled 1.3-kb  kanamycin-resistance cassette DNA probe Figure 2
A representative Southern blot demonstrating hybridization of the genomic DNA cleaved with EcoRI with a 
DIG-labeled 1.3-kb kanamycin-resistance cassette DNA probe. Lane 1: pUC4K plasmid DNA (positive control); lane 
2: S. Typhimurium LB5010 (negative control); lanes 3 to 10: K1 to K8 strains, respectively.BMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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Classification of the mutants according to the functions or 
putative functions of genes disrupted by the transposon 
insertions
The 54 mutants listed in Table 1 were classified according
to the functions or putative functions of the ORFs dis-
rupted by the transposons. We classified the mutants into
the 12 categories: fimbrial biosynthesis and regulation,
putative cytoplasmic protein, global regulator protein, cell
membrane associated protein, cell envelope associated
protein, periplasmic protein, ribosome modulation fac-
tor, type III secretion system protein, prophage-derived
protein, sensor protein, transcription termination factor,
and enzymes. Nine mutants that had defects in fimA,
fimC,  fimD,  fimH,  fimY,  fimZ,  lpfB,  pefI, and stbC  were
placed in the fimbrial biosynthesis and regulation cate-
gory. FimA is the major subunit of the type 1 fimbrial
shaft, while the adhesion protein, FimH, confers the bind-
ing specificity of type 1 fimbriae [18,21]. FimC and FimD
serve as the chaperone and molecular usher for type 1 fim-
briae [18]. FimZ and FimY are positive regulators of fimA
[14,19]. Since all these genes are involved in type 1 fim-
brial biosynthesis and regulation, disruption of these
genes caused the mutants to produce no fimbriae at all in
either culture condition. Three mutants produced type 1
fimbriae in both culture conditions and had transposons
inserted in other fimbrial related genes. K70 had a defect
in  lpfB, the chaperone protein for long polar fimbriae
[22]. K61 had a defect in pefI, which involves the regula-
tion of plasmid-encoded fimbriae [23]. K23 had a trans-
poson inserted in stbC that encodes an outer membrane
usher protein for Stb fimbriae in S. Typhimurium. The
usher protein facilitates anchoring the developing fim-
brial structure to the outer membrane [24].
The K1 and K28 mutants exhibited type 1 fimbriae in both
static broth and on solid agar media. The gene products
involved are putative cytoplasmic proteins, and their
functions remain to be characterized. The K15 mutant had
a transposon inserted in the hupA gene whose product is
the histone-like DNA-binding protein, HU, a small, basic,
thermostable protein involving DNA replication [25]. The
K15 mutant and another mutant K46 that has disruption
in  lrp  encoding leucine-responsive regulatory protein
(LRP) did not exhibit type 1 fimbriae in either culture con-
dition. Membrane associated proteins possess transmem-
brane domains. K17 had interruption of yhjV encoding
protein similar to the tryptophan/tyrosine permease fam-
ily in Escherichia coli [26]. The putative protein affected in
K39 is a sodium/glucose cotransporter protein which
belongs to a superfamily of membrane proteins responsi-
ble for the uphill transport of substrates coupled to the
downhill transport of Na+ [27]. The mgtB and narK genes,
defective in K72 and K30 respectively, are involved in
Mg2+ and nitrate/nitrite transportation, respectively [28].
Disruption of the rmf gene impaired the 70S ribosome
dimerization and resulted in inhibition of S. Typhimu-
rium to produce type 1 fimbriae as seen in K56 [29]. The
ssaB, ssaV, and invB belong to members of the type III
secretion system, which is important in the pathogenesis
of S. Typhimurium. The ssaB and ssaV mutants did not
produce type 1 fimbriae in either culture condition,
whereas the invB mutant produced type 1 fimbriae in both
culture conditions. Two mutants, K11 and K19, possessed
insertions in genes involved in synthesis of putative phage
tail proteins [30]. K33 had an insertion in the gene encod-
ing for a type III translocated protein, SseI, carried by the
prophage Gifsy-2 [31]. Two mutants, K51 and K58, had
transposons inserted into genes which encode the sensor
part of the two-component regulatory system. SsrA is asso-
ciated with the type III secretion system for the patho-
genicity island II [32], while YehU in S. Typhimurium
remains to be characterized. NusA binds to the RNA
polymerase core enzyme and functions as a transcription
termination factor [33]. The K73 carrying transposon in
nusA did not produce type 1 fimbriae in either culture
condition.
Among the mutants, 21 of 54 mutants (almost 39%) were
in the category of enzymes comprising the largest group of
the mutants. The enzymes detected in these mutants
could be further divided into endoribonuclease (K3),
restriction-modification enzyme (K5), protease (K38),
tRNA modification enzyme (K43), the enzyme for
lipopolysaccharide synthesis (K68), and primarily the
enzymes required for general metabolism.
Complementation test
Table 2 summarizes the results of the complementation
test for K3 cafA, K5 res, K43 miaA, K48 ubiB and K73 nusA
mutant strains. The K48 ubiB mutant strain produced type
1 fimbriae constitutively regardless grown in static broth
or on solid agar culture condition. Transforming the plas-
mid pUbiB that contained the coding sequence of ubiB
conferred the K48ubiB mutant to exhibit the type 1 fim-
brial phenotype as seen in S. Typhimurium LB5010.
Transforming a plasmid possessing the coding sequence
of res to K5 res mutant did repress the type 1 fimbriae to
express on solid agar as the parental strain. However, the
complemented strain did not produce type 1 fimbriae in
static broth culture. The complemented strains K3 cafA
(pCafA), K43 miaA  (pMiaA) and K73 nusA  (pNusA)
remained unchanged as their respective mutant strains,
which did not produce type 1 fimbriae in either culture
condition.
Reverse transcription polymerase chain reaction (RT-PCR) 
analysis
Total RNA from the parental strain S. Typhimurium
LB5010, K48 ubiB mutant, and K48 ubiB (pUbiB) were
prepared and analyzed for fimA  mRNA and 16S rRNABMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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expression by RT-PCR. Figure 3 showed the RT-PCR anal-
ysis results. As for the parental strain LB5010, the fimA
expression obtained from the static broth was approxi-
mately 4.5 fold (1: 0.22) of that obtained from the agar
culture condition. For the K48 ubiB mutant, expression of
fimA (static broth) was about 60% (1: 1.74) of the fimA
(agar). When K48 ubiB  strain harboured the plasmid
pUbiB, fimA expression (broth) was about 2.6 fold (1:
0.39) of fimA (agar). As a control, 16S rRNA was con-
stantly expressed in all the strains tested.
Discussion
It is not surprising that many bacterial fimbriae have the
ability to switch expression from a fimbriate to a non-fim-
briate phenotype. Since bacterial population may face
unpredictable milieu during their life cycle, having cells in
both fimbriate and non-fimbriate phases offers the bacte-
rial population an advantage of surviving in the diverse
situations it will encounter [34]. The mechanisms that
control the fimbrial regulation have been described in
detail for only few fimbrial types. For example, the regula-
tion in E. coli type 1 fimbriae is primarily controlled by
inversion of a 314-bp segment of DNA (fim switch region)
upstream of the fimA gene coding for the major fimbrial
subunit [35]. Accessory proteins including the integration
host factor (IHF), LRP and the histone-like nucleoid-struc-
turing (H-NS) protein, also bind to the fim switch region
to re-orientate the DNA into a configuration favourable
for inversion [36-38]. Interestingly, the E. coli K-12 strain
also possesses the sfm gene cluster (sfmACDHFZU), which
is the orthologue of S. Typhimurium fim gene cluster [39].
Nevertheless not much characterization has been per-
formed on sfm. The control system for type 1 fimbriae in
S. Typhimurium differs from that of E. coli. No DNA inver-
sion event has been detected and several fim gene prod-
ucts have been implicated as regulators of type 1 fimbrial
expression [13-18,40]. Previous studies did not reveal that
global regulator like IHF or H-NS play a role in S. Typh-
imurium type 1 fimbrial expression. In order to explore
other elements outside the fim gene cluster that might also
participate in type 1 fimbrial expression, we constructed a
transposon library of S. Typhimurium. From the mutants
that no longer exhibited the same type 1 fimbrial pheno-
types as the parental strain whether grown on solid agar
and in static broth cultures, 12 groups were classified
according to the putative functions of the genes that were
interrupted by the transposons. Not surprisingly, several
mutants that had defects in the fim genes did not produce
type1 fimbriae in either condition. The mutants possess-
ing transposons in fimA, fimC, fimD, fimH, fimZ, and fimY
all exhibited the predicted phenotypes. These fim genes
are required for type 1 fimbrial biogenesis or regulation,
and disruption of these genes causes the bacteria to be
non-fimbriate in either condition. Interestingly, the
present study identified 3 mutants that had defective
genes for other fimbrial systems, and they produced type
1 fimbriae in both culture conditions. K23 had a transpo-
son inserted in stbC that encodes the fimbrial usher pro-
tein for Stb fimbriae [41]. K70 had insertion in fimbrial
chaperone protein for long polar fimbriae (Lpf). Those
two gene products are involved in fimbrial biogenesis.
How disruption of the outer membrane usher gene, stbC,
of the Stb fimbrial system affects another fimbrial system
poses an interesting research topic. We did try to comple-
ment the stbC mutant with a recombinant plasmid pos-
sessing the stbC  coding sequence. However, the stbC
mutant exhibited resistance to a battery of antibiotics,
including ampicillin and chloramphenicol those fre-
quently used in molecular cloning. This unexpected find-
ing impeded us to transforming available plasmids into
this strain for the time being. PefI identified in K61 is the
homolog of PapI in E. coli. PefI negatively regulates the
production of PefA, the major fimbrial subunit of plas-
mid-encoded fimbriae (Pef) [42]. Cross-talk between dif-
Table 2: Phenotypic expression of type 1 fimbriae by the selected mutant and the complemented strains
Strain Plasmid transformed Phenotypic expression of type 1 fimbriae by bacteria grown on or ina
agar broth
LB5010 none - +
K3 cafA none - -
K3 cafA pCafA - -
K5 res none + +
K5 res pRes - -
K43 miaA none - -
K43 miaA pMiaA - -
K48 ubiB none + +
K48 ubiB pUbiB - +
K73 nusA none - -
K73 nusA pNusA - -
a: phenotypic expression of type 1 fimbriae was determined by mannose-sensitive yeast agglutination test.BMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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ferent fimbrial systems within the same microorganism
has been demonstrated previously. For example, minor
fimbrin of type 1 and F1C fimbriae of E. coli can be recip-
rocally exchanged to generate hybrid fimbriae with
changed receptor specificities [43]. The regulator PapB of
pyelonephritis-associated pili (Pap) prevents inversion of
the fim switch controlling the expression of type 1 fim-
briae in the same E. coli strain [44]. Recently Nuccio et al.
also demonstrated that the presence of type 1 fimbrial
biosynthesis genes interfered with the expression of plas-
mid-encoded fimbriae in S. Typhimurium [45]. Although
additional research is required to elucidate the interaction
of different fimbrial systems, our results did stress the
observation that different types of fimbriae may coordi-
nate for their own benefit.
A global regulator, LRP, has been demonstrated to play a
role in the regulation of both type 1 fimbriae and P fim-
briae of E. coli and Pef of S. Typhimurium. Recently
McFarland et al. demonstrated that an lrp knockout S.
Typhimurium strain did not produce type 1 fimbriae and
Lrp is a positive regulator for fim gene expression by inter-
acting with the fimZ promoter region [20]. FimZ is a pos-
itive regulator for fimA [14]. Their data suggested that a
positive contribution of fim gene expression by Lrp/fimZ
promoter interaction may be due to the displacement of
H-NS, a repressor for fimZ [20,46]. The K46 mutant with
the transposon inserted into lrp did not produce type 1
fimbriae in either culture condition. Our result concurred
with their finding. The role that lrp plays in terms of type
1 fimbrial regulation in S. Typhimurium becomes appar-
ent.
RT-PCR for fimA transcription Figure 3
RT-PCR for fimA transcription. RT-PCR assays were used to monitor fimA and 16S rRNA transcription in the parental 
strain LB5010, ubiB mutant, and ubiB (pUbiB) strain. The intensities of the bands for each strain were determined by densitom-
etry and expressed (Arabic numbers) relative to the value for fimA transcription obtained from the static LB broth culture con-
dition. The intensities of 16S rRNA shown indicates that equivalent amounts of total RNA were used in the experiment.BMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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Several S. Typhimurium strains had transposons inserted
in the genes that encode enzymes. The K3 strain had a
defect in cafA that encodes a ribonuclease named RNase G
in  E. coli. Umitsuki et al. reported that RNase G was
involved in the in vivo degradation of adhE mRNA which
encodes a fermentative alcohol dehydrogenase, AdhE
[47]. A mutation at cafA resulted in accumulation of adhE
mRNA and prolonged the half-life of its mRNA. Interest-
ingly, the K16 strain had a mutation in the gene that
encodes alcohol dehydrogenase. The K16 strain constitu-
tively expressed type 1 fimbriae. Overexpression of AdhE
inhibited type 1 fimbrial expression, while the absence of
AdhE caused type 1 fimbrial expression on solid agar or in
static broth. How an enzyme involved in metabolism
influences fimbrial expression is not clear, but previous
studies demonstrated that type 1 fimbrial expression was
linked to the nutrient status of the bacterial encounter.
Broth culture supplemented with glucose favours Shigella
flexneri remaining in a non-fimbriate state [6]. Morgen-
roth and Duguid described a S. Typhimurium biotype
called the FIRN strain; it is non-type 1 fimbriate, non-
inositol-fermenting, and non-rhamnose-fermenting [48].
The genes controlling fimbrial expression may be linked
to the genes involved in carbohydrate metabolism. Inter-
estingly, similar to the K16 strain, a variety of mutants in
the present study having transposons inserted in the genes
encoding "house-keeping" enzymes all constitutively
exhibited type 1 fimbriae. Barak et al. used transposon
mutagenesis to identify genetic determinants required for
S. Newport to attach to plant tissue [49]. They also found
that alcohol dehydrogenase, hydrolase, bacteriophage
protein, and several membrane associated proteins,
including transporter protein, similar to our findings,
were the essential components for this Salmonella serotype
to adhere to plant tissue [49]. The ability of Salmonella to
colonize plant tissue and modulate type 1 fimbrial expres-
sion may share a common regulatory network.
A complementation test allowed us to examine if provid-
ing the coding sequence of the gene carried in a plasmid
back to the mutant stain defective in such a gene would
switch the phenotype of type 1 fimbrial expression to that
originally observed. A comprehensive complementation
test is not within the scope of the present study; however,
we did test some strains. The complemented K3 cafA
(pCafA), K43 miaA  (pMiaA), and K73 nusA  (pNusA)
strains did not exhibit the type 1 fimbrial phenotype as
the parental strain. Polar effect caused by the transposon
could be one of the reasons. Another possibility could be
due to the gene dosage effect conferred by the cloning vec-
tor. The K5 res (pRes) strain did repress the type 1 fimbrial
production on solid agar as the parental strain LB5010.
However, in static broth culture, the complemented strain
did not exhibit type 1 fimbriae. The res gene, encoding for
the restriction subunit of type III restriction-modification
(R-M) system of S. Typhimurium, locates upstream of the
mod gene which encodes the methyltransferase subunit of
R-M system. Since Res subunit requires Mod to form a
complex to recognize and cleave DNA [50], failure of mod
expression caused by polar effect could account for the
partially complemented phenotype of the K5res (pRes)
strain. NusA is a transcription termination factor and
under some circumstance it may also function as a tran-
scription elongation factor [51]. The ability of NusA to
enhance RNA polymerase pausing would result in tight
coupling of transcription and translation, thus interferes
with the Rho-mRNA interactions and consequently blocks
termination of transcription [52]. The transposon inserted
in nusA in K73 strain could cause transcription/translation
coupling defect in a variety of genes including those that
may affect fim expression. The pNusA transformed in K73
strain may not produce precise stoichiometric ration of
NusA, leading K73 nusA  (pNusA) strain remained
unchanged as the K73 nusA strain. MiaA is an isopente-
nylpyrophosphate transferase that is required for tRNA
modification. Ericson and Björk demonstrated that a miaA
mutant in S. Typhimurium LT2 which was deficient in 2-
methylthio-N6-(4-hydroxyisopentenyl) adenosine
(ms2io6A37) in its tRNA induced pleiotropic effects on
bacterial physiology such as reduced growth rate and
polypeptide chain elongation rate [53]. Non-fimbriate
phenotype exhibited by K43 miaA strain in both culture
conditions could be the result of such pleiotropic effects.
The K48 ubiB mutant transformed with the pUbiB plas-
mid restored the type 1 fimbrial phenotype as the parental
strain LB5010. The K48 ubiB (pUbiB) cultured on agar did
not agglutinate yeast cells. Although signals of both
LB5010 and K48 ubiB  (pUbiB) from agar could be
detected by densitometry in RT-PCR assay, we argued that
such fimA amount would not be enough for scoring posi-
tive in yeast agglutination test. Our complementation
assay did prove that the ubiB mutant could exhibit the
same phenotype as LB5010 when it harboured a plasmid
containing the coding sequence of ubiB. The ubiB in S.
Typhimurium could encode a NAD(P)H-flavin-reductase,
whose homologue in E. coli has been proved to be
required for the first monooxygenase step in ubiquinone
biosynthesis [54]. How a gene involving in biosynthesis
of ubiquinone, an essential component of electron trans-
port chain influences type 1 fimbrial expression is cur-
rently unknown. However, Leonard et al. reported that
UbiB protein contains motifs found in eukaryotic-type
protein kinase [55]. It was speculated that phosphoryla-
tion may be required for ubiquinone biosynthesis-activat-
ing proteins [55]. Possibly UbiB would also
phosphorylate another substrate protein that affects fimA
expression. The function of ubiB in S. Typhimurium and
the relationship of ubiB and fim expression demands more
careful characterization. Our data clearly showed that an
ubiB mutant produced fimA at the condition that eitherBMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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favours or inhibits type 1 fimbrial expression and comple-
menting this mutant with a plasmid possessing ubiB cod-
ing sequence restored it to the phenotype similar to the
parental strain.
The present study revealed that the genetic determinants
other than the fim genes could have the potential to affect
type 1 fimbrial expression in response to different stand-
ard laboratory culture conditions. However, a battery of
genes identified by transposon mutagenesis still requires
detail characterization to validate its linkage to fimbrial
expression. The phenotype caused by polar effect is one of
the drawbacks in this kind of study. Validation of the
genes of interest that are associated with type 1 fimbrial
expression in S. Typhimurium is presently under investi-
gation in our laboratory.
Conclusion
The ability to switch between fimbrial expressions in bac-
teria may be beneficial for survival. Fimbriate bacteria
may facilitate colonizing host cells at certain stages of
infection, while non-fimbriate bacteria may also have
their own role to play, for example, as in avoiding recog-
nition by phagocytes, or allowing the bacteria to shed and
colonize another site on the host. Compared to E. coli, Sal-
monella has a higher survival rate in the external environ-
ment, which promotes transmission to a new host [56].
Persistent infection of Salmonella in the environment is
enhanced by adhesion and biofilm formation, both of
which involve fimbrial appendages [21]. How S. Typh-
imurium fluctuates between type 1 fimbriate phase and
non-fimbriate phase in vivo remains to be uncovered.
Nonetheless the present study reveals that several genetic
determinants may be associated with the ability of S.
Typhimurium to modulate type 1 fimbrial expression
between solid agar and static broth culture conditions.
These two laboratory culture conditions may to some
extent mimic the environmental milieu that Salmonella
would encounter. We report here that other gene products
besides those in the fim gene cluster are also required for
type 1 fimbrial expression. How each gene influences type
1 fimbrial expression is an interesting research topic
which warrants further investigation.
Methods
Bacterial strains, media, culture conditions, primers and 
plasmids
The S. Typhimurium strain used in the present study is S.
Typhimurium LB5010, a LT2 strain derivative [57]. This
strain produces type 1 fimbriae and is fimbrial phase var-
iable [57]. E.coli  JM109 strain was used for molecular
cloning [58]. The primers and plasmids used in the
present study are listed in Table 3 and Table 4, respec-
tively. Bacteria were grown in Luria-Bertani (LB) broth
(Difco/Becton Dickinson, Franklin Lakes, NJ) or plated
on LB agar [59]. Media were supplemented with antibiot-
ics when required at the following concentrations: kan-
amycin, 50 μg/ml; ampicillin, 100 μg/ml;
chloramphenicol, 20 μg/ml. The above antibiotics were
obtained from Sigma (St. Louis, MO).
Construction of a transposon mutant library of S. 
Typhimurium
A transposon mutant library of S. Typhimurium was con-
structed using the EZ::TN <KAN-2> Tnp Transposome sys-
tem (Epicentre, Madison, WI). This system contains the
transposon Tn903 which possesses a kanamycin resist-
ance cassette. Briefly, 1 μl of the transposome mixture was
placed in 40 μl of S. Typhimurium-competent cells and
electroporated into the cells for transposition to occur.
The electroporation conditions were set as follows using
ECM 630 (BTX, Pittsburgh, PA): voltage of 1.70 kV, resist-
ance of 125 ohms, and capacitance of 50 μF. Immediately
after electroporation, 1 ml of S.O.C medium (Invitrogen,
Carlsbad, CA) was added to the cuvette and the medium/
cell mixture was transferred to a tube and incubated at
37°C with constant shaking for 1 h. Four milliliters of LB
broth was added to dilute the bacterial cells, and a-100 μl
of aliquot was evenly spread on the kanamycin-contain-
ing LB agar.
Screening of S. Typhimurium transposon mutants that 
exhibited different type 1 fimbrial phenotypes than the 
parental strain
The transformants grown on LB agar supplemented with
kanamycin were randomly selected. Each colony was
streaked on LB agar and then inoculated into 10 ml of LB
broth. The LB agar plates were incubated at 37°C for 18 h
while the broth preparations were incubated statically at
37°C for 48 h. Bacterial cells from the solid agar were col-
Table 3: Oligonucleotide primers used in the present study
Primer Sequence (5'-3')
kan-5 TAACATCATTGGCAACGCTACCT
kan-6 GCATCGGGCTTCCCATACAATCG
kan-7 GTCGCACCTGATTGCCCGACATT
cafA-F ATACGACTCACAACCTTGCTTTGCCGGACG
cafA-R TTTCTGCGCAGGATATTAGTGGCTATGTCG
res-F CATTGTCATTTACGGCTACTCT
res-R ACGATAACCTTCAAGTCAAC
miaA-F CTGCTGGCGGATGTTGAGCGGCTATGT
miaA-R CGCAATGCGTTCAGGAACGGATCTTGT
nusA-F CCGTCCTATGTTCACTGCCGAT
nusA-R CTGCTGTACCAGGCGATCCACGGAAAC
ubiB-F GGTCGTCCTATTGTTAAAGATCCTGA
ubiB-R CGCAATACAAAGCCTGTAGATATTCA
16S-F TTCCTCCAGATCTCTCTACGCA
16S-R GTGGCTAATACCGCATAACG
fimA-F ACTATTGCGAGTCTGATGTTTG
fimA-R CGTATTTCATGATAAAGGTGGCBMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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lected by a sterile loop and resuspended in 100 μl of 1 ×
phosphate-buffered saline (PBS). Cells in the broth
medium were collected by centrifugation, and the pellet
was resuspended in 100 μl of 1 × PBS. Subsequently, 30 μl
of a 3% (vol/vol) suspension of C.albicans in PBS and an
equal amount of bacterial cells to be tested were mixed
together on a glass slide [11]. Visible agglutination after
gentle agitation indicated a positive reaction for the pres-
ence of type 1 fimbriae. Any bacterial suspension that pro-
duced type 1 fimbriae was further mixed with C. albicans
along with 3% (wt/vol) of a D-mannose solution (Sigma).
The mannose-sensitive agglutination conferred by type 1
fimbriae was inhibited in the presence of mannose.
Southern hybridization
Southern hybridization analysis was used to detect the
presence of the kanamycin resistance cassette on the S.
Typhimurium genomic DNA. Genomic DNAs from S.
Typhimurium LB5010 and the mutant strains that were
no longer type 1 fimbrial phase variable were isolated
using a MasterPure DNA Purification Kit (Epicentre). The
genomic DNA preparations were cleaved by EcoRI, and
the DNA fragments were separated by electrophoresis in a
0.7% agarose gel. EcoRI was chosen to cut the genomic
DNA since there was no EcoRI site within the kanamycin
resistance cassette of Tn903. A DNA probe derived from
the kanamycin resistance cassette sequence was hybrid-
ized to one band in the Southern blot if the transposition
had occurred only once. The DNA was soaked in a dena-
turing solution (0.5 M NaOH and 1 M NaCl) twice for 15
min each time and a neutralization solution (3 M NaCl,
0.5 M Tris-HCl) for 30 min with continuous agitation at
room temperature. The DNA was then transferred onto a
nylon membrane by a vacuum blotter (trans-Vac, Hoefer,
San Francisco, CA) with 10 × SSC and cross-linked to the
membrane by exposure to short-wavelength UV light
from a UV Spectrolinker (Spectronics, Westbury, NY). The
1.3-kb kanamycin resistance cassette-containing DNA
fragment was cleaved by Hind III from the pUC4K plas-
mid and isolated from the agarose gel using a Montage
Gel Extraction Kit (Millipore, Bedford, MA). Probe labe-
ling and hybridization were performed using a DIG High
Prime DNA Labeling and Detection Starter Kit II (Roche
Diagnostics, Mannheim, Germany) according to the pro-
tocols provided by the manufacturer. The 1.3-kb DNA
probe was labeled by the randomly primed incorporation
of digoxigenin-labeled dUTP. Briefly, hybridization to the
blot was performed at 68°C in a standard buffer (5 × SSC,
0.1% N-lauroylsarcosine, 0.02% SDS, and 1% blocking
reagent) for 16 h. Two 5-min washes were performed at
room temperature in a 2 × SSC (1 × SSC is comprised of
0.15 M NaCl and 0.015 M sodium citrate)-0.1% SDS solu-
tion. The blot was then washed with two 15-min washes
in 0.1 × SSC-0.1% SDS solutions at 68°C. Hybrids were
detected using an antibody conjugate (anti-digoxigenin-
alkaline phosphate conjugate) and NBT/BCIP (18.75 mg/
ml nitrobluetetrazolium chloride and 9.4 mg/ml of a 5-
bromo-4-chloro-3-indolyl-phosphate in 67% [vol/vol]
DMSO) solution.
Identification of transposon insertion sites
The transposon insertion sites in the mutants of interest
were identified by a three-step PCR using a DNA Walking
SpeedUp Premix Kit (Seegene, Seoul, Korea). This kit uses
annealing control primer (ACP) technology [60,61]. The
DW-ACP primers provided by the kit are designed to cap-
ture unknown target sites, and with primers internal to the
known sequence, will amplify DNA fragments possessing
the junction region of known and adjacent sequences. The
first PCR reaction was performed independently in four
individual PCR tubes using the kan-5 primer internal to
the kanamycin resistance cassette with one of the DW-
ACP 1, 2, 3, or 4 primers. The total 50 μl of the PCR con-
tained genomic DNA of the mutant under study, 4 μl of
the DW-ACP primer, the kan-5 primer, distilled water,
and 25 μl of 2 × SeeAmp ACP Master Mix II. The PCR pro-
gram was set as follows: one cycle at 94°C for 5 min, 42°C
for 1 min, and 72°C for 2 min; followed by 30 cycles of
94°C 30 s, 55°C 30 s, and 72°C for 100 s. Finally the PCR
was extended at 72°C for 7 min. The product from the
first PCR was purified using Montage PCR Filter Units
(Millipore) and was used as the template for the second
PCR. The second PCR with a final volume of 20 μl con-
tained the first PCR product as the template, 1 μl DW-
ACPN, a kanamycin resistance cassette-specific kan-6
primer upstream from kan-5, distilled water, and 10 μl of
Table 4: The plasmids used in the present study
Plasmid Genotype or relevant featuresa Reference or source
pUC4K 3.9 kb vector, Kanr Amr Amersham Biosciences
yT&A 2.7 kb cloning vector; Amr Yeasten Biotech
pCafA 1.3 kb DNA fragment containing cafA cloned into yT&A; Amr This study
pRes 3.7 kb DNA fragment containing res cloned into yT&A; Amr This study
pMiaA 1.2 kb DNA fragment containing miaA cloned into yT&A; Amr This study
pNusA 1.8 kb DNA fragment containing nusA cloned into yT&A; Amr This study
pUbiB 988 bp DNA fragment containing ubiB cloned into yT&A; Amr This study
a: Kanr, kanamycin resistant; Amr, ampicillin resistant.BMC Microbiology 2008, 8:126 http://www.biomedcentral.com/1471-2180/8/126
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2 × SeeAmp ACP Master MixII. The PCR program was set
as follows: denaturation at 94°C for 3 min; 35 cycles of
94°C 30 s, 56°C 30 s, and 72°C 100 s; then the PCR was
extended at 72°C for 7 min. The third PCR used 2 μl of the
second PCR product (without purification) as the tem-
plate. The remaining components consisted of 1 μl uni-
versal primer, 1 μl of the kan-7 primer upstream from kan-
6, distilled water, and 10 μl of 2 × SeeAmp ACP Master
MixII. The third PCR reaction consisted of 94°C for 3 min;
followed by 35 cycles of 94°C for 30 s, 60°C for 30 s, and
72°C for 100 s; then the PCR was extended at 72°C for 7
min. The products from the third PCR were purified from
the agarose gel and sequenced by using the kan-7 primer
to determine the junction sequence where the transposon
was inserted into the genomic DNA. The sequence of the
junction region of the transposon was compared against
the S. Typhimurium LT2 genome sequence [GenBank: NC
003197].
Complementation Test
Primers used for complementation test (cafA-F, cafA-R,
res-F, res-R, miaA-F, miaA-R, nusA-F, nusA-R, ubiB-F and
ubiB-R) were listed in Table 3 and were used to amplify
genomic DNA of S. Typhimurium LB5010. The PCR prod-
uct that contained the full coding sequence of the respec-
tive gene was cloned into the yT&A vector (Yeasten
Biotech, Taipei, Taiwan) according to the protocol pro-
vided by the manufacturer. The resulting plasmid was
transformed into the corresponding mutant strain by elec-
troporation. The complemented strains were tested for
type 1 fimbrial expression in static broth and on solid agar
medium by yeast agglutination test.
Reverse transcription polymerase chain reaction (RT-PCR) 
analysis
The bacteria were stabilized by adding RNAprotect bacte-
ria reagent (Qiagen, Valencia, CA). Total RNA was pre-
pared by using an RNeasy Mini Kit (Qiagen) and RNase-
free DNase (1 unit/1 μg RNA) according to the manufac-
turer's protocol. RT-PCR was performed using a Fast-Run
HotStart RT-PCR (AMV) kit (Protech, Taipei, Taiwan).
Briefly, RNA was denatured at 58°C for 5 min, followed
by cDNA synthesis at 42°C for 30 min and inactivation at
94°C for 2 min. The following PCR conditions are: 35
cycles of denaturation at 94°C for 30 s, annealing at 54°C
for 30 s, and extension at 72°C for 30 s. An additional
extension was performed at 72°C for 5 min. Primers
fimA-F and fimA-R were used to detect the mRNA expres-
sion of fimA, while 16S-F and 16S-R primers were used to
detect the mRNA expression of 16S rRNA as a control.
Densitometry was performed using the Image Quant ver-
sion 5.2 image analysis software (Molecular Dynamics,
GE Healthcare, UK).
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